Masimo

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Masimo and other ETFs, options, and stocks.

About MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge.

CEO

Catherine M. Szyman

CEOCatherine M. Szyman

Employees

9,200

Employees9,200

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1989

Founded1989

Employees

9,200

Employees9,200

MASI Key Statistics

Market cap

7.64B

Market cap7.64B

Price-Earnings ratio

-16.42

Price-Earnings ratio-16.42

Dividend yield

—

Dividend yield—

Average volume

543.95K

Average volume543.95K

High today

$142.02

High today$142.02

Low today

$138.68

Low today$138.68

Open price

$141.78

Open price$141.78

Volume

783.56K

Volume783.56K

52 Week high

$194.88

52 Week high$194.88

52 Week low

$133.70

52 Week low$133.70

MASI News

Simply Wall St 4d

What Masimo's Study on SpO2 Accuracy Across Skin Tones Means for Shareholders

Masimo Corp. recently announced an update on its ongoing clinical study evaluating the accuracy of RD SET® SpO2 sensors across different skin tones, emphasizing...

TipRanks 5d

Masimo’s Study on Pulse Oximetry and Skin Pigmentation: A Potential Game-Changer

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unl...

TipRanks 5d

Masimo Corp. Explores New Frontiers in Sleep Therapy with PROSOMNIA Study

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unl...

Analyst ratings

80%

of 10 ratings

Buy

80%

Hold

20%

Sell

People also own

Based on the portfolios of people who own MASI. This list is generated using Robinhood data, and it’s not a recommendation.